Summary
Gao Peng is a Chief Scientific Officer with over eight years of leadership in therapeutic mRNA and antibody development, currently steering R&D strategy and IND-enabling programs at Abogen Biosciences. He built Abogen’s mRNA platform from concept to clinical readiness, blending hands-on platform engineering with programmatic oversight of preclinical, CMC, and regulatory efforts. Earlier roles spanned antibody engineering, bispecific and half-life extension platforms, and translational imaging and infectious-disease antibody discovery from academic labs to biopharma. Gao combines deep academic training (PhD in Biochemistry and Molecular Biology) with pragmatic CRO/CDMO management and contract negotiation experience that accelerates clinical translation. Based in Greater Houston, he is known for integrating analytical, formulation, and platform teams to shorten development timelines while expanding technological scope through external collaborations. A quirky aside: his GitHub bio reads "not a human," reflecting a wry scientist’s sense of humor behind rigorous translational work.
8 years of coding experience
7 years of employment as a software developer
Ph.D. Biochemistry and Molecular Biology, Ph.D. Biochemistry and Molecular Biology at The University of Texas at Austin
Master of Science (MS) Molecular Genetics, Master of Science (MS) Molecular Genetics at Nankai University
English, Chinese